Demonstrate ROI of ESG Investment, Navigate Evolving Compliance & Geopolitics, & Improve Reporting Efficiency to Traverse Global Uncertainty & Futureproof Efficient Sustainability Initiatives
As the life sciences industry continued to navigate tighter budgets, leaner teams, evolving regulations, and growing pressure to demonstrate business value, the need for practical, business-focused sustainability strategies remained more important than ever.
The 5th Annual Sustainability in Life Sciences Summit (formerly ESG in Life Sciences Summit) brought together sustainability, ESG, compliance, procurement, and operations leaders from across pharma, biotech, medical devices, and life science organizations to address the industry's most pressing challenges. The 2027 agenda focused on demonstrating ROI, navigating regulatory uncertainty, improving reporting efficiency, strengthening supply chain resilience, and driving measurable business impact amid ongoing geopolitical change.
Representatives from leading organizations including Merck, Bristol Myers Squibb, Sanofi, Amgen, MilliporeSigma, Thermo Fisher Scientific, Hologic, and many others came together to benchmark strategies, share practical lessons learned, and build meaningful connections with peers that faced similar challenges.
Through discussions on sustainability reporting, Scope 3 emissions, supplier engagement, operational efficiency, social impact, and securing leadership buy-in, attendees gained actionable insights to help futureproof their sustainability strategies and deliver long-term value in an increasingly complex and uncertain landscape.
2026 Attending Companies